Project Grant K01CA297147
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$191K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Kansas City, KS 66160, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $192,489 to the University of Alabama at Birmingham (UAB) from February 1, 2025 to January 31, 2030. The project aims to evaluate the implementation and impact of oncology financial navigation, an evidence-based intervention to help cancer patients manage treatment-related financial hardship. Key activities include: Tracking implementation strategies and their effect on outcomes like...
This $172,197 Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) aims to establish and refine processes to facilitate clinical trials in cancer interception (active cancer prevention) at the University of Kansas Cancer Center (KUCC). Key objectives include: Hiring project navigators to support study approvals for principal investigators in non-oncology departments outside KUCC Training research coordinators in cancer prevention trial processes...
The National Cancer Institute (NCI) awarded a $140,854 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Fred Hutchinson Cancer Center in Seattle, WA. The purpose of this K99/R00 Pathway to Independence Award is to provide research training and support the transition of Dr. Karl Cristie Figuracion, a postdoctoral research fellow, to become an independent scientist focused on interventions to reduce symptom burden, improve quality of life, and enhance return-to-work...
This Project Grant award, in the amount of $269,942, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award aims to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake and address disparities in LCS among Black and Hispanic communities served by community health centers. The key products and services to be delivered include: 1) Jointly...
This Project Grant award of $586,106 from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) supports a 5-year effort to refine and pilot test a psychosocial intervention for patients with malignant primary central nervous system tumors. The intervention incorporates elements of Acceptance and Commitment Therapy to address unmet supportive care needs and alleviate distress in this patient population. Specifically, the project aims to: 1) refine the intervention...
This Project Grant award, identified as R25CA291554, was provided by the National Cancer Institute (NCI), part of the National Institutes of Health, under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award's objective is to test a comprehensive national accelerator program called INCITE (Increasing Caregiver Support Implementation through Training and Education) to train cancer centers and their staff in identifying, implementing, evaluating, and sustaining...
The National Cancer Institute (NCI) awarded a 5-year, $162,160 Project Grant (CFDA 93.398 - Cancer Research Manpower) to The Ohio State University to improve the assessment of patient-reported outcomes (PROs) among Black/African-American cancer patients. The research will involve qualitative interviews with Black cancer patients and their providers to understand barriers and facilitators to completing PROs and social determinants of health (SDH) measures. This knowledge will inform the...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a $1,338,648 hybrid effectiveness-implementation trial of the CARES intervention at the University of Pittsburgh. CARES is an integrated electronic health record-based screening and stepped collaborative care program designed to improve patient-centered outcomes for over 18 million Americans living with cancer who experience clinically significant levels of depression,...
This Cooperative Agreement award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $946,500.00 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to test the effectiveness of pragmatic strategies to promote high-quality, evidence-based cancer survivorship care for rural adult cancer survivors in primary care practices. The project aims to assess the impact of interventions such as virtual scribes,...
This $192,433 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program supports a research project to pilot an implementation strategy for increasing the use of mainstream genetic testing (MGT) for colorectal cancer (CRC) patients. The University of Alabama at Birmingham (UAB) will assess barriers to implementing MGT among healthcare providers and institutional stakeholders, as well as patient perceptions, to inform a multi-level...